ChemicalBook >> CAS DataBase List >>Vedolizumab
Vedolizumab
- CAS No.
- 943609-66-3
- Chemical Name:
- Vedolizumab
- Synonyms
- Vedolizumab;Vedolizumab USP/EP/BP;Vedolizumab (anti-α4β7-integrin);Research Grade Vedolizumab(DHC98802)
- CBNumber:
- CB54187577
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
Last updated:2024-07-02 08:55:11
storage temp. | Store at -80°C |
---|---|
solubility | Soluble in DMSO |
form | Solid |
color | White to off-white |
FDA UNII | 9RV78Q2002 |
NCI Drug Dictionary | vedolizumab |
ATC code | L04AA33 |
Vedolizumab price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-7825 | Vedolizumab 99.64% | 943609-66-3 | 1mg | $400 | 2021-12-16 | Buy |
Biosynth Carbosynth | BV165597 | Vedolizumab | 943609-66-3 | 1mg | $600 | 2021-12-16 | Buy |
ChemScene | CS-7825 | Vedolizumab 99.64% | 943609-66-3 | 5mg | $740 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | ATB0023426 | VEDOLIZUMAB 95.00% | 943609-66-3 | 5MG | $996.68 | 2021-12-16 | Buy |
ChemScene | CS-7825 | Vedolizumab 99.64% | 943609-66-3 | 25mg | $2800 | 2021-12-16 | Buy |
Vedolizumab Chemical Properties,Uses,Production
Clinical Use
Monoclonal antibody:
Treatment of ulcerative colitis and Crohn’s disease
Drug interactions
Potentially hazardous interactions with other drugs
Live vaccines: risk of generalised infections - avoid.
Metabolism
The expected consequence of metabolism is proteolytic degradation to small peptides and individual amino acids, and receptor-mediated clearance. The exact elimination route of vedolizumab is unknown although renal clearance is expected to be negligible.
Vedolizumab Preparation Products And Raw materials
Raw materials
Preparation Products
Vedolizumab Suppliers
Global( 65)Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Hubei Ipure Biology Co., Ltd | +8613367258412 | ada@ipurechemical.com | China | 10326 | 58 |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | laboratory@coreychem.com | China | 30250 | 58 |
HONG KONG IPURE BIOLOGY CO.,LIMITED | 86 18062405514 18062405514 | ada@ipurechemical.com | CHINA | 3465 | 58 |
Shaanxi Dideu Medichem Co. Ltd | +86-029-89586680 +86-18192503167 | 1026@dideu.com | China | 8840 | 58 |
Shanghai Minbiotech Co., Ltd. | +8617315815539 | sales@minbiotech.com | CHINA | 129 | 58 |
AFINE CHEMICALS LIMITED | +86-0571-85134551 | info@afinechem.com | China | 15395 | 58 |
Baoji Guokang Healthchem co.,ltd | +8615604608665 15604608665 | dominicguo@gk-bio.com | CHINA | 9427 | 58 |
Hefei Hirisun Pharmatech Co., Ltd | +8615056975894 | shawn@hirisunpharm.com | CHINA | 9923 | 58 |
Hangzhou Huarong Pharm Co., Ltd. | 571-86758373 +8613588754946 | sales@huarongpharm.com | CHINA | 3149 | 58 |
Nantong HI-FUTURE Biology Co., Ltd. | +undefined18051384581 | sales@chemhifuture.com | China | 3136 | 58 |
Vedolizumab
Vedolizumab USP/EP/BP
Research Grade Vedolizumab(DHC98802)
Vedolizumab (anti-α4β7-integrin)
943609-66-3
943609-66-6